Skip to content

Drug interactions

Basiliximab + Denosumab

Severity: Moderate

Basiliximab and Denosumab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Denosumab labeling warns of serious infections in patients with impaired immunity. Basiliximab is an immunosuppressant used in transplantation, so the infection risk may be additive.

What this interaction means in plain words

Basiliximab and Denosumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Basiliximab belongs to Miscellaneous; Denosumab belongs to Oncology.

Evidence level: Low

Why it happens

Additive immunosuppression: denosumab inhibits RANKL signalling in immune cells, and basiliximab blocks IL-2 receptor-mediated T-cell activation.

What to do

Monitor for signs of infection during combined use. Treat infections promptly and reassess the need for denosumab if serious infections develop.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Basiliximab and Denosumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Basiliximab with Denosumab?

MediHelp rates the interaction as moderate. Basiliximab and Denosumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Denosumab labeling warns of serious infections in patients with impaired immunity. Basiliximab is an immunosuppressant used in transplantation, so the infection risk may be additive.

How serious is the interaction between Basiliximab and Denosumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for signs of infection during combined use. Treat infections promptly and reassess the need for denosumab if serious infections develop.

What other medicines interact with Denosumab?

MediHelp also lists interactions of Denosumab with, for example, Abatacept, Adalimumab, Alefacept. The full list is on the Denosumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in